Literature DB >> 16639692

Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms.

H-C Lien1, Y-S Lu, A-L Cheng, W-C Chang, Y-M Jeng, Y-H Kuo, C-S Huang, K-J Chang, Y-T Yao.   

Abstract

Glucocorticoid receptor (GR) is a steroid hormone receptor that has been shown to play important roles in mammary development and differentiation, and has been implicated in breast tumourigenesis, but its precise biological significance in mammary pathophysiology remains unclear. In order to generate a comprehensive expression profile for GR in normal versus neoplastic breast tissues, GR expression was investigated in situ in 400 human breast tissue samples, comprising normal tissue and a range of benign, pre-invasive, and invasive lesions, using immunohistochemical assays. The novel expression of GR in myoepithelium, not observed in luminal epithelium, not only demonstrates expression patterns exclusive to the alpha form of oestrogen receptor and progesterone receptor and suggests distinctive functions between GR and these two important steroid hormone receptors in the breast, but may also indicate unique physiological and perhaps pathological roles for the myoepithelium in mediating the effects of glucocorticoid hormones in the breast. The strong expression of GR in metaplastic carcinomas (94.4%) and malignant phyllodes tumours (92.3%) suggests a pathogenetic role for GR, and implies that targeting GR in these tumours may have potential therapeutic application. However, studies on the roles of GR in mammary carcinogenesis should be interpreted with great caution, based on the lack of GR expression in cancer cells in the great majority (98.2%) of non-metaplastic carcinomas, which has gone unnoticed in previous studies. This marked discrepancy warrants a re-examination of the biological roles of GR in the pathophysiology of breast malignancy. The lack of methylation in the promoter region of the GR gene in all 118 non-metaplastic carcinomas, as demonstrated by methylation-specific PCR and bisulphite DNA sequencing analysis, indicates that methylation is less likely to play a role in the reduction of GR expression in non-metaplastic carcinoma of the breast. Copyright (c) 2006 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639692     DOI: 10.1002/path.1982

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  22 in total

1.  Expression of 11β-hydroxysteroid dehydrogenase type 1 in breast cancer and adjacent non-malignant tissue. An immunocytochemical study.

Authors:  Lu Lu; Gang Zhao; Van Luu-The; Johanne Ouellet; Zhinmin Fan; Fernand Labrie; Georges Pelletier
Journal:  Pathol Oncol Res       Date:  2011-01-26       Impact factor: 3.201

Review 2.  Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression.

Authors:  Henriett Butz; Attila Patócs
Journal:  Cancer Metastasis Rev       Date:  2022-06-27       Impact factor: 9.264

3.  Glucocorticoid receptor expression in breast cancer associates with older patient age.

Authors:  Larissa Belova; Bertha Delgado; Masha Kocherginsky; Amal Melhem; Olufunmilayo I Olopade; Suzanne D Conzen
Journal:  Breast Cancer Res Treat       Date:  2008-07-31       Impact factor: 4.872

4.  Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors.

Authors:  Kirsten A Nesset; Ami M Perri; Christopher R Mueller
Journal:  Epigenetics       Date:  2014-03-12       Impact factor: 4.528

5.  Overexpression of glucocorticoid receptor in human pancreatic cancer and in xenografts. An immunohistochemical study.

Authors:  Sándor Békási; Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2009-02-28       Impact factor: 3.201

Review 6.  Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.

Authors:  Lara Malik Noureddine; Olivier Trédan; Nader Hussein; Bassam Badran; Muriel Le Romancer; Coralie Poulard
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

Review 7.  Stress and breast cancer: from epidemiology to molecular biology.

Authors:  Lilia Antonova; Kristan Aronson; Christopher R Mueller
Journal:  Breast Cancer Res       Date:  2011-04-21       Impact factor: 6.466

8.  Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line.

Authors:  Frederic Buxant; Nadège Kindt; Guy Laurent; Jean-Christophe Noël; Sven Saussez
Journal:  Mol Med Rep       Date:  2015-06-12       Impact factor: 2.952

9.  Causal Attributions in Breast Cancer Patients Planning to Undergo Adjuvant Endocrine Therapy.

Authors:  Seul Ki Park; Yul Ha Min; Minsun Lee; Sae Byul Lee
Journal:  Int J Environ Res Public Health       Date:  2021-05-31       Impact factor: 3.390

10.  Genetic Variation and Immunohistochemical Localization of the Glucocorticoid Receptor in Breast Cancer Cases from the Breast Cancer Care in Chicago Cohort.

Authors:  Umaima Al-Alem; Abeer M Mahmoud; Ken Batai; Ebony Shah-Williams; Peter H Gann; Rick Kittles; Garth H Rauscher
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.